Dotti Patch, Extended Release
Product Images NDC 72162-2033

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Dotti (NDC 72162-2033). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Dotti Estradiol Transdermal System 1)

FDA Label Image

4a (Dotti Estradiol Transdermal System 10)

FDA Label Image

4b (Dotti Estradiol Transdermal System 11)

FDA Label Image

4c (Dotti Estradiol Transdermal System 12)

FDA Label Image

4d (Dotti Estradiol Transdermal System 13)

FDA Label Image

4e (Dotti Estradiol Transdermal System 14)

FDA Label Image

4f (Dotti Estradiol Transdermal System 15)

FDA Label Image

4g (Dotti Estradiol Transdermal System 16)

FDA Label Image

2 (Dotti Estradiol Transdermal System 2)

FDA Label Image

Figure 1 (Dotti Estradiol Transdermal System 3)

FDA Label Image

2 (Dotti Estradiol Transdermal System 4)

FDA Label Image

2 (Dotti Estradiol Transdermal System 5)

This text appears to be a table showing the percentage change from baseline for different treatments involving the use of Estradiol at varying dosages over the course of several weeks. The table also includes a placebo control. However, there is some difficulty in interpreting the text due to errors in the scanning process, such as missing characters and extraneous symbols, so the information provided may not be complete or accurate.*

FDA Label Image

1 (Dotti Estradiol Transdermal System 6)

This appears to be a table showing the treatment duration and % change from baseline for different types of Estradiol medications and Placebo. There are four different time points (Week 26, Week 52, Week 78, and Week 104) being evaluated. The table includes the medication name, dosage, and symbols indicating whether data is available or not.*

FDA Label Image

1 (Dotti Estradiol Transdermal System 7)

The text provides instructions for the use of DOTTI™, which is an estradiol transdermal system. The system appears to have a patch that must be changed on specific days indicated in a chart. The chart shows different pairs of days where the patch should be changed and repeats itself in a pattern. It is unclear what the purpose of the system is or any potential side effects.*

FDA Label Image

2 (Dotti Estradiol Transdermal System 8)

FDA Label Image

3 (Dotti Estradiol Transdermal System 9)

FDA Label Image

Label (Lbl721622033)

This is a description of a pharmaceutical product called DOTTI® which is a transdermal patch containing 0.470mg of estradiol, USP in each 2.83cm² system. The package is not child-resistant. The NDC number is 72162-2033-2. It is to be applied immediately after removing from pouch and stored at 20-25°C with excursions permitted between 15-30°C. It delivers 0.0375 mg/day and is only available with a prescription. The product is manufactured by Amneal Pharmaceuticals and was relabeled by Bryant Ranch Prepack, Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.